Arne Helland (born 1977), specialist in clinical pharmacology and head of section/senior consultant at the Department of Clinical Pharmacology, St. Olavs Hospital (Trondheim University Hospital).
The author has completed the ICMJE form and reports no conflicts of interest.
Jon Andsnes Berg (born 1978), specialist in clinical pharmacology and acting senior consultant at the Section of Clinical Pharmacology, Laboratory of Clinical Biochemistry, Haukeland University Hospital.
The author has completed the ICMJE form and reports no conflicts of interest.
Ingebjørg Gustavsen (born 1972), specialist in clinical pharmacology and head of section/senior consultant at the Ullevål branch of the Department of Pharmacology, Oslo University Hospital.
The author has completed the ICMJE form and reports no conflicts of interest.
Lena Aronsen (born 1971), specialist in clinical pharmacology and senior consultant at the Department of Laboratory Medicine, University Hospital of North Norway.
The author has completed the ICMJE form and reports no conflicts of interest.
Marianne Arnestad (born 1970) was a specialty registrar in clinical pharmacology at the Centre for Psychopharmacology, Diakonhjemmet Hospital in connection with the preparation of the report on which this article is based. She is now a senior consultant at the Domain for Forensic Sciences, Norwegian Institute of Public Health, and a board member of the Norwegian Association of Clinical Pharmacology.
The author has completed the ICMJE form and reports no conflicts of interest.
Sigrid Narum (born 1969), specialist in clinical pharmacology and head of section/senior consultant at the Centre for Psychopharmacology, Diakonhjemmet Hospital and chair of the specialist committee in clinical pharmacology.
The author has completed the ICMJE form and reports no conflicts of interest.
Skurtveit S, Sakshaug S, Hjellvik V et al. Bruk av vanedannende legemidler i Norge 2005 – 2013. Oslo: Folkehelseinstituttet, 2014.
4.
Hiemke C, Baumann P, Bergemann N et al. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. Pharmacopsychiatry 2011; 44: 195 – 235. [CrossRef]
5.
Schulz M, Iwersen-Bergmann S, Andresen H et al. Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics. Crit Care 2012; 16: R136. [PubMed] [CrossRef]
Svendsen K, Borchgrevink P, Fredheim O et al. Choosing the unit of measurement counts: the use of oral morphine equivalents in studies of opioid consumption is a useful addition to defined daily doses. Palliat Med 2011; 25: 725 – 32. [PubMed] [CrossRef]
This article was published more than 12 months ago and we have therefore closed it for new comments.
Published: 15 March 2016
Tidsskr Nor Legeforen 15 March 2016
doi:
10.4045/tidsskr.16.0030
Received 11 January 2016 and accepted 8 February 2016. Editor: Ketil Slagstad.
If you do not see the PDF file or want to save the file, you can right-click on the PDF icon. Select «Save target / file as ...» and then retrieve the PDF file in, for example, Acrobat Reader.